Related references
Note: Only part of the references are listed.ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2020)
Infliximab in inflammatory bowel disease
Konstantinos Papamichael et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2019)
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Jason Lloyd-Price et al.
NATURE (2019)
Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases
Konrad Aden et al.
GASTROENTEROLOGY (2019)
Microbial network disturbances in relapsing refractory Crohn's disease
Bahtiyar Yilmaz et al.
NATURE MEDICINE (2019)
Database resources of the National Center for Biotechnology Information
Eric W. Sayers et al.
NUCLEIC ACIDS RESEARCH (2019)
A Narrative Review on Anti-Tumor Necrosis Factor α Therapies in Inflammatory Bowel Disease During Pregnancy: Immunoglobulin Placental Translocation and its Impact
Joana Roseira et al.
ACTA MEDICA PORTUGUESA (2019)
Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy
Yizhong Wang et al.
JOURNAL OF CROHNS & COLITIS (2018)
Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
Youlian Zhou et al.
MSYSTEMS (2018)
Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis
E. J. Mao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases
Mingming Sun et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches
R. Balfour Sartor et al.
GASTROENTEROLOGY (2017)
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Gilaad G. Kaplan et al.
GASTROENTEROLOGY (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials
A. Cholapranee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
L. Vuitton et al.
GUT (2016)
Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
Maria K. Magnusson et al.
JOURNAL OF CROHNS & COLITIS (2016)
Short, but Smart: SCFAs Train T Cells in the Gut to Fight Autoimmunity in the Brain
Yangzom D. Bhutia et al.
IMMUNITY (2015)
Redirection of epithelial immune responses by short-chain fatty acids through inhibition of histone deacetylases
May Young Lin et al.
FRONTIERS IN IMMUNOLOGY (2015)
Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD
Vicky De Preter et al.
GUT (2015)
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Aleksandar D. Kostic et al.
GASTROENTEROLOGY (2014)
A Phylogenomic View of Ecological Specialization in the Lachnospiraceae, a Family of Digestive Tract-Associated Bacteria
Conor J. Meehan et al.
GENOME BIOLOGY AND EVOLUTION (2014)
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
Kathleen Machiels et al.
GUT (2014)
Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis
E. Varela et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Towards a unified paradigm for sequence-based identification of fungi
Urmas Koljalg et al.
MOLECULAR ECOLOGY (2013)
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Morgan G. I. Langille et al.
NATURE BIOTECHNOLOGY (2013)
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Robert C. Edgar
NATURE METHODS (2013)
Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut
Elaine O. Petrof et al.
MICROBIOME (2013)
Antibiotics in early life alter the murine colonic microbiome and adiposity
Ilseung Cho et al.
NATURE (2012)
The gut microbiota in IBD
Chaysavanh Manichanh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Xochitl C. Morgan et al.
GENOME BIOLOGY (2012)
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response
Geert R. D'Haens et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
UCHIME improves sensitivity and speed of chimera detection
Robert C. Edgar et al.
BIOINFORMATICS (2011)
Invasive Potential of Gut Mucosa-derived Fusobacterium nucleatum Positively Correlates with IBD Status of the Host
Jaclyn Strauss et al.
INFLAMMATORY BOWEL DISEASES (2011)
UniFrac: an effective distance metric for microbial community comparison
Catherine Lozupone et al.
ISME JOURNAL (2011)
Metagenomic biomarker discovery and explanation
Nicola Segata et al.
GENOME BIOLOGY (2011)
QIIME allows analysis of high-throughput community sequencing data
J. Gregory Caporaso et al.
NATURE METHODS (2010)
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
F. Schnitzler et al.
GUT (2009)
Lactobacillus casei Downregulates Commensals' Inflammatory Signals in Crohn's Disease Mucosa
Marta Llopis et al.
INFLAMMATORY BOWEL DISEASES (2009)
Low Counts of Faecalibacterium prausnitzii in Colitis Microbiota
H. Sokol et al.
INFLAMMATORY BOWEL DISEASES (2009)
G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation
Christian Sina et al.
JOURNAL OF IMMUNOLOGY (2009)
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Kendle M. Maslowski et al.
NATURE (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease
Sofia Tedelind et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease
A Darfeuille-Michaud et al.
GASTROENTEROLOGY (2004)
Share Paper
